Aspivix

About:

ASPIVIX is developing a device that makes gynecological procedures more comfortable for patients.

Website: https://www.aspivix.com/

Twitter/X: Aspivix_Health

Top Investors: Venture Kick, Innosuisse, Zürcher Kantonal Bank, EASME - EU Executive Agency for SMEs, Hemex

Description:

ASPIVIX is developing a new generation of medical devices that make gynecological procedures gentler and safer for women and gynecologists. The first device, CAREVIX, is designed to prevent cervix bleeding using a suction technology to replace traumatic tenaculum (forceps).

Total Funding Amount:

$13.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Renens, Vaud, Switzerland

Founded Date:

2015-01-01

Contact Email:

contact(AT)aspivix.com

Founders:

David Finci, Julien Finci, Mathieu Horras

Number of Employees:

1-10

Last Funding Date:

2024-06-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai